The Globe and Mail

Go to the Globe and Mail homepage

Jump to main navigationJump to main content

AdChoices
 

GlaxoSmithKline PLC

NYSE: GSK
Last

(U.S.) $37.67

Today's change-0.03 -0.08%
Updated December 5 4:02 PM EST. Delayed by at least 15 minutes.
 

GlaxoSmithKline PLC

NYSE: GSK
Last

(U.S.) $37.67

Today's change-0.03 -0.08%
Updated December 5 4:02 PM EST. Delayed by at least 15 minutes.

GlaxoSmithKline PLC down slightly

GlaxoSmithKline PLC closed down just (U.S.)$0.03 Monday to (U.S.)$37.67. Over the last five days, shares have lost 1.62% and are down 6.64% for the last year to date. This security has underperformed the S&P 500 by 11.86% during the last year.

Key company metrics

  • Open(U.S.) $37.82
  • Previous close(U.S.) $37.70
  • High(U.S.) $37.85
  • Low(U.S.) $37.56
  • Bid / Ask(U.S.) $37.64 / (U.S.) $37.72
  • YTD % change-6.64%
  • Volume3,785,795
  • Average volume (10-day)3,936,790
  • Average volume (1-month)4,494,895
  • Average volume (3-month)3,253,139
  • 52-week range(U.S.) $37.36 to (U.S.) $45.58
  • Beta0.89
  • Trailing P/E246.97×
  • P/E 1 year forward14.65×
  • Forward PEG1.25×
  • Indicated annual dividend(U.S.) $2.09
  • Dividend yield5.54%
  • Trailing EPS(U.S.) $0.15
Updated December 5 4:02 PM EST. Delayed by at least 15 minutes.
  • Income Statement
  • Balance Sheet
  • Cash Flow
Quarter | Annual
Q3/2016Q2/2016Q1/2016Q4/2015
Fiscal Quarter Endvalues in $ millions unless otherwise notedSep 30, 201609/30/2016Jun 30, 201606/30/2016Mar 31, 201603/31/2016Dec 31, 201512/31/2015
Revenue7,5426,5326,2296,286
Total other revenue--------
Total revenue7,5426,5326,2296,286
Gross profit5,0994,4764,1594,082
Total cost of revenue2,4432,0562,0702,204
Total operating expense6,1116,6835,5066,539
Selling / general / administrative2,2322,0752,0762,122
Research & development876800775846
Depreciation / amortization11101010
Interest expense (income), net operating--------
Unusual expense (income)6561,825666910
Other operating expenses, total-107-83-91447
Operating income1,431-151723-253
Interest income (expense), net non-operating--------
Gain (loss) on sale of assets--------
Other--------
Income before tax1,274-318560-416
Income after tax885-492352-428
Income tax, total38917420812
Net income808-435282-354
Total adjustments to net income--------
Net income before extra. items808-435282-354
Minority interest-7757-7074
Equity in affiliates--------
U.S. GAAP adjustment--------
Inc. avail. to common excl. extra. items808-435282-354
Inc. avail. to common incl. extra. items808-435282-354
Diluted net income809-435282-354
Dilution adjustment1--00
Diluted weighted average shares4,9024,8594,8904,837
Diluted EPS excluding extraordinary itemsvalue per share0.17-0.090.06-0.07
Dividends per sharevalue per share0.190.190.190.23
Diluted normalized EPSvalue per share0.260.150.140.05